By Prof. Samuel LARTEY,\xa0www.pefghana.orgArtificial Intelligence has become one of the most powerful forces shaping the contemporary digital era. It represents a major shift in human civilisation ...

When you're ready to start your first chat, click or tap New chat, type your prompt in the composer, and press Enter or tap ...

The new open-source atlas, generated by an AI tool called ESMFold2, vastly increases the known protein universe ...

Cable music program “The Show” is officially making its return seven months after going off the air! On May 13, YNA reported that “The Show” is preparing to resume broadcasts, with its first episode ...

Welcome! This repository contains REST API tutorial samples that demonstrate how to use the Azure AI Content Understanding service directly via HTTP calls with thin Python convenience wrappers. These ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

Wisconsin is becoming a popular location for data centers due to its climate, water access, and affordable land. The majority of a data center's water footprint comes from the offsite electricity ...

The US federal government’s central energy information agency is planning to implement a mandatory nationwide survey of data centers focused on their energy use, according to a letter seen by WIRED.

Dutch fitness giant Basic-Fit announced that hackers breached its systems and gained access to information belonging to a million of its customers. The company operates the largest gym chain in Europe ...

A Pennsylvania Uber driver woke up to a slithery surprise after picking up two passengers who attended a reptile show. Officers from the Exeter Township Police Department in Berks County were called ...

NEW ORLEANS--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with ...